TVARDI THERAPEUTICS, INC. Operating Lease, Payments
TVARDI THERAPEUTICS, INC. (TVRD) reported Operating Lease, Payments of $50.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. operating lease, payments for the quarter ending 2026-06-30 was $50.00K, a 0.00% change year-over-year.
- TVARDI THERAPEUTICS, INC. operating lease, payments for the quarter ending 2026-03-31 was $51.00K, a 2.00% increase year-over-year.
- TVARDI THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-12-31 was $50.00K, a 2.04% increase year-over-year.
- TVARDI THERAPEUTICS, INC. operating lease, payments for the quarter ending 2025-09-30 was $50.00K, a 0.00% change year-over-year.
- TVARDI THERAPEUTICS, INC. operating lease, payments for fiscal 2025 was $200.00K, a 1.52% increase from fiscal 2024.
- TVARDI THERAPEUTICS, INC. operating lease, payments for fiscal 2024 was $197.00K, a 90.11% decline from fiscal 2023.
- TVARDI THERAPEUTICS, INC. operating lease, payments for fiscal 2023 was $1.99M, a 1.79% increase from fiscal 2022.
- TVARDI THERAPEUTICS, INC. operating lease, payments for fiscal 2022 was $1.96M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.00K 10-Q · filed 2026-08-14 | $101.00K 10-Q · filed 2026-08-14 | $151.00K derived: sum of 3 quarters · filed 2026-08-14 | $201.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $51.00K 10-Q · filed 2026-05-08 | $101.00K derived: sum of 2 quarters · filed 2026-05-08 | $151.00K derived: sum of 3 quarters · filed 2026-05-08 | $201.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $100.00K derived: sum of 2 quarters · filed 2026-03-31 | $150.00K derived: sum of 3 quarters · filed 2026-08-14 | $200.00K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $50.00K 10-Q · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2026-08-14 | $150.00K 10-Q · filed 2025-11-13 | $199.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $50.00K 10-Q · filed 2026-08-14 | $100.00K 10-Q · filed 2026-08-14 | $149.00K derived: sum of 3 quarters · filed 2026-08-14 | $199.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $50.00K 10-Q · filed 2026-05-08 | $99.00K derived: sum of 2 quarters · filed 2026-05-08 | $149.00K derived: sum of 3 quarters · filed 2026-05-08 | $198.00K derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $99.00K derived: sum of 2 quarters · filed 2026-03-31 | $148.00K derived: sum of 3 quarters · filed 2026-03-31 | $197.00K 10-K · filed 2026-03-31 | $4.36M 10-K · filed 2025-03-11 | ||
| 2024-09-30 | $50.00K 10-Q · filed 2025-11-13 | $4.36M 10-Q · filed 2024-11-14 | $99.00K derived: sum of 2 quarters · filed 2025-11-13 | $148.00K 10-Q · filed 2025-11-13 | $4.36M 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $49.00K 10-Q · filed 2025-08-14 | $98.00K 10-Q · filed 2025-08-14 | |||||
| 2023-12-31 | $503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.00M derived: sum of 2 quarters · filed 2025-03-11 | $1.50M derived: sum of 3 quarters · filed 2025-03-11 | $1.99M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $500.00K 10-Q · filed 2024-11-14 | $996.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.49M 10-Q · filed 2024-11-14 | $1.98M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $496.00K 10-Q · filed 2024-08-14 | $990.00K 10-Q · filed 2024-08-14 | $1.48M derived: sum of 3 quarters · filed 2024-08-14 | $1.98M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | $494.00K 10-Q · filed 2024-05-13 | $988.00K derived: sum of 2 quarters · filed 2024-05-13 | $1.48M derived: sum of 3 quarters · filed 2024-05-13 | $1.97M derived: sum of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $985.00K derived: sum of 2 quarters · filed 2024-03-06 | $1.47M derived: sum of 3 quarters · filed 2024-03-06 | $1.96M 10-K · filed 2024-03-06 | |||
| 2022-09-30 | $491.00K 10-Q · filed 2023-11-13 | $978.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.46M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | $487.00K 10-Q · filed 2023-08-07 | $972.00K 10-Q · filed 2023-08-07 | |||||
| 2022-03-31 | $485.00K 10-Q · filed 2023-05-15 | ||||||
| 2021-09-30 | $482.00K 10-Q · filed 2022-11-07 | $960.00K derived: sum of 2 quarters · filed 2022-11-07 | $1.44M 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | $478.00K 10-Q · filed 2022-08-08 | $954.00K 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | $476.00K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |